ticlopidine has been researched along with Exanthem in 16 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Excerpt | Relevance | Reference |
---|---|---|
" The antiplatelet agent clopidogrel has become a mainstay of treatment for patients with acute coronary syndromes and stroke, and to reduce ischemic complications after percutaneous coronary and peripheral interventions." | 5.12 | Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience. ( Fasano, MB; Horwitz, PA; Walker, NE, 2006) |
"Ticlopidine was subsequently discontinued due to severe diarrhea." | 2.44 | Clopidogrel desensitization: case report and review of published protocols. ( Garner, J; Hergott, L; Owen, P; Page, RL, 2008) |
"Ticlopidine has a relative high rate of side-effects." | 1.34 | Incidence of side-effects of ticlopidine after sirolimus-eluting stent implantation. ( Fukushima, K; Kobayashi, Y; Komuro, I; Kuroda, N; Miyazaki, A; Nakamura, Y; Nakayama, T; Okuno, T; Sakakibara, M; Shimizu, Y, 2007) |
"Ticlopidine is known to cause cutaneous adverse reactions in up to 5." | 1.30 | Rash in patients receiving ticlopidine after intracoronary stent placement. ( Bell, DM; Whetsel, TR, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 13 (81.25) | 29.6817 |
2010's | 2 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pallares, MJ | 1 |
Powers, ER | 1 |
Zwerner, PL | 1 |
Fowler, A | 1 |
Reeves, R | 1 |
Nappi, JM | 1 |
Kammer, RT | 1 |
Walsh, SN | 1 |
Kerchner, K | 1 |
Sangüeza, OP | 1 |
Lokhandwala, JO | 1 |
Best, PJ | 2 |
Butterfield, JH | 1 |
Skelding, KA | 1 |
Scott, T | 1 |
Blankenship, JC | 1 |
Buckley, JW | 1 |
Berger, PB | 2 |
van Werkum, JW | 1 |
Braber, TL | 1 |
Verheggen, PW | 1 |
Van Der Have-Roeffel, SM | 1 |
Lokhandwala, J | 1 |
Henry, Y | 1 |
Camara, MG | 2 |
Almeda, FQ | 2 |
Walker, NE | 2 |
Fasano, MB | 2 |
Horwitz, PA | 2 |
Fukushima, K | 1 |
Kobayashi, Y | 1 |
Okuno, T | 1 |
Nakamura, Y | 1 |
Sakakibara, M | 1 |
Nakayama, T | 1 |
Kuroda, N | 1 |
Miyazaki, A | 1 |
Shimizu, Y | 1 |
Komuro, I | 1 |
Satish, B | 1 |
Tressa, K | 1 |
Harish, CR | 1 |
Hobbs, RA | 1 |
Owen, P | 1 |
Garner, J | 1 |
Hergott, L | 1 |
Page, RL | 1 |
Whetsel, TR | 1 |
Bell, DM | 1 |
Cannavò, SP | 1 |
Borgia, F | 1 |
Guarneri, F | 1 |
Vaccaro, M | 1 |
Taniuchi, M | 1 |
Kurz, HI | 1 |
Lasala, JM | 1 |
1 review available for ticlopidine and Exanthem
Article | Year |
---|---|
Clopidogrel desensitization: case report and review of published protocols.
Topics: Cardiac Catheterization; Clinical Protocols; Clopidogrel; Coronary Artery Disease; Desensitization, | 2008 |
2 trials available for ticlopidine and Exanthem
Article | Year |
---|---|
Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.
Topics: Adult; Aged; Clopidogrel; Coronary Disease; Desensitization, Immunologic; Dose-Response Relationship | 2006 |
Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population.
Topics: Abciximab; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Coronary Thrombosis; Eptifibatide; | 2001 |
13 other studies available for ticlopidine and Exanthem
Article | Year |
---|---|
Barriers to clopidogrel adherence following placement of drug-eluting stents.
Topics: Adult; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Drug-Eluting Stents; Exanthema | 2009 |
Successful clopidogrel desensitization after drug-eluting stent implantation.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Desensitization, Immunologic; Drug-Eluting Ste | 2009 |
Challenge. What is your diagnosis? Answer. Primary nodal diffuse large B-cell lymphoma with secondary cutaneous involvement.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clopidogrel; C | 2009 |
Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel.
Topics: Aged; Angioedema; Clopidogrel; Drug Hypersensitivity; Exanthema; Female; Humans; Male; Neutropenia; | 2009 |
Prasugrel as alternative treatment strategy in a case with a hypersensitivity reaction to clopidogrel.
Topics: Aged; Angioedema; Clopidogrel; Drug Hypersensitivity; Exanthema; Fever; Humans; Male; Piperazines; P | 2011 |
Allergic reactions to clopidogrel and cross-reactivity to other agents.
Topics: Adrenal Cortex Hormones; Angioplasty, Balloon, Coronary; Anticoagulants; Clopidogrel; Desensitizatio | 2011 |
Clopidogrel (Plavix) desensitization: a case series.
Topics: Aged; Clopidogrel; Desensitization, Immunologic; Erythema; Exanthema; Female; Humans; Male; Platelet | 2005 |
Clopidogrel (Plavix) desensitization protocol.
Topics: Aged; Clopidogrel; Desensitization, Immunologic; Erythema; Exanthema; Female; Humans; Male; Platelet | 2007 |
Incidence of side-effects of ticlopidine after sirolimus-eluting stent implantation.
Topics: Aged; Blood Vessel Prosthesis Implantation; Chemical and Drug Induced Liver Injury; Coronary Thrombo | 2007 |
Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Disease Progression; Drug H | 2007 |
Clopidogrel desensitization protocol for the treatment of thienopyridine hypersensitivity.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Clinical Protocols; Clopidogrel; Desensitization, Immuno | 2007 |
Rash in patients receiving ticlopidine after intracoronary stent placement.
Topics: Aged; Coronary Vessels; Exanthema; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Retrospec | 1999 |
Acute generalized exanthematous pustulosis following use of ticlopidine.
Topics: Aged; Exanthema; Female; Humans; Platelet Aggregation Inhibitors; Skin Diseases, Vesiculobullous; Ti | 2000 |